SIAPS has received funding from the US President’s Malaria Initiative (PMI) to work in eight countries—Angola, Burundi, Democratic Republic of the Congo (DRC), Ethiopia, Kenya, Guinea, Mali, and South Sudan—to strengthen pharmaceutical systems for improved malaria control. This report synthesizes the pharmaceutical systems strengthening efforts of SIAPS and documents how the approach was used to support … Read more
Archive PMI
Strengthening the Malaria Supply Chain in Niger
SIAPS Program provides support to the US President’s Malaria Initiative (PMI) country programs to address challenges to ensuring an uninterrupted supply of high-quality medicines and commodities as well as their appropriate use. SIAPS Program collaborates with PMI and field programs to strengthen pharmaceutical management systems for the benefit of national malaria control programs (NMCP). In … Read more
PMI Coordinator Visits SIAPS-DRC
The Democratic Republic of the Congo (DRC), with one highest malaria incidence rates in the world, is a priority country for the President’s Malaria Initiative (PMI). PMI has played a major role in the country’s fight against malaria, having dedicated $50m toward eliminating the disease in DRC over the last five years. PMI Coordinator Rear … Read more
Malaria PMI Quarterly Updates April-June 2015
According to the World Health Organization (WHO), 1 malaria mortality rates fell by 47% globally, and by 54% in Africa between 2000 and 2013. During this period, an estimated 4.3 million malaria deaths were averted globally, primarily as a result of the scale-up of interventions. However, much remains to be done. Although 55 countries are … Read more
Analysis of the Regulatory Capacity to Assure the Quality of Antimalarial Medicines in Selected Countries of the Greater Mekong Subregion of Asia
SIAPS conducted a review of regulatory and quality assurance efforts in the GMS with the following objectives— To inform PMI of past and current initiatives to improve the capacity of the region to combat counterfeit, substandard, and banned antimalarial medicines To understand the current barriers to effective medicine quality control for malaria To recommend specific … Read more
Malaria PMI Quarterly Updates October-December 2014
According to the 2013 World Malaria Report,1 malaria incidence was reduced by about 31% and mortality rates by 49%in the World Health Organization (WHO) African Region between 2000 and 2012. These substantial reductions occurred as a result of a major scale-up of vector control interventions, diagnostic testing, and treatment with artemisinin-based combination therapies (ACTs). However, … Read more
SIAPS/PMI – AMDM Scale-Up Sites Baseline Assessment
The President’s Malaria Initiative (PMI) is an interagency initiative led by the US Agency for International Development (USAID) with the US Centers for Disease Control and Prevention (CDC). PMI aims to reduce malaria-related mortality by 50% in 15 countries in sub-Saharan Africa by 2010. It plans to meet this goal by achieving 85% coverage of … Read more
Malaria PMI Quarterly Updates July–September 2014
According to the 2013 World Malaria Report, malaria incidence and mortality rates were reduced by about 31% and 49%, respectively, in the World Health Organization (WHO) African Region between 2000 and 2012. These substantial reductions occurred as a result of a major scale-up of vector control interventions, diagnostic testing, and treatment with artemisinin-based combination therapies (ACTs). … Read more
Malaria Quarterly Updates January–March 2014
This report briefly describes the major activities that SIAPS conducted at the global level and in Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Guinea, Mali, and South Sudan between January and March 2014.
Malaria Quarterly Updates October-December 2013
This report briefly describes the major activities that SIAPS carried out at the global level and in Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Guinea, Mali, and South Sudan between October and December 2013.